Moderna, Inc. (MRNA)
196.48
+9.02
(+4.81%)
USD |
NASDAQ |
Oct 07, 16:00
195.36
-1.12
(-0.57%)
After-Hours: 20:00
Moderna Market Cap : 78.40B for Oct. 7, 2026
Market Cap Chart
Historical Market Cap Data
| Date | Value |
|---|---|
| October 07, 2026 | 78.40B |
| October 06, 2026 | 74.80B |
| October 05, 2026 | 81.08B |
| October 02, 2026 | 75.81B |
| October 01, 2026 | 75.39B |
| September 30, 2026 | 76.84B |
| September 29, 2026 | 81.18B |
| September 28, 2026 | 78.71B |
| September 25, 2026 | 79.35B |
| September 24, 2026 | 77.73B |
| September 23, 2026 | 72.66B |
| September 22, 2026 | 72.84B |
| September 21, 2026 | 69.00B |
| September 18, 2026 | 61.46B |
| September 17, 2026 | 63.07B |
| September 16, 2026 | 58.10B |
| September 15, 2026 | 57.36B |
| September 14, 2026 | 58.53B |
| September 11, 2026 | 57.44B |
| September 10, 2026 | 54.51B |
| September 09, 2026 | 54.11B |
| September 08, 2026 | 55.99B |
| September 04, 2026 | 58.07B |
| September 03, 2026 | 59.40B |
| September 02, 2026 | 60.17B |
| Date | Value |
|---|---|
| September 01, 2026 | 61.55B |
| August 31, 2026 | 56.00B |
| August 28, 2026 | 55.06B |
| August 27, 2026 | 56.97B |
| August 26, 2026 | 59.71B |
| August 25, 2026 | 63.37B |
| August 24, 2026 | 55.42B |
| August 21, 2026 | 57.91B |
| August 20, 2026 | 53.19B |
| August 19, 2026 | 69.58B |
| August 18, 2026 | 25.12B |
| August 17, 2026 | 25.72B |
| August 14, 2026 | 25.26B |
| August 13, 2026 | 25.40B |
| August 12, 2026 | 25.40B |
| August 11, 2026 | 24.17B |
| August 10, 2026 | 23.86B |
| August 07, 2026 | 23.61B |
| August 06, 2026 | 21.49B |
| August 05, 2026 | 22.45B |
| August 04, 2026 | 22.74B |
| August 03, 2026 | 22.00B |
| July 31, 2026 | 21.87B |
| July 30, 2026 | 23.11B |
| July 29, 2026 | 21.74B |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| Sarepta Therapeutics, Inc. | 1.848B |
| BioNTech SE | 23.93B |
| Revolution Medicines, Inc. | 43.03B |
| Twist Bioscience Corp. | 9.755B |
| Arrowhead Pharmaceuticals, Inc. | 8.677B |
Market Cap Related Metrics
| PS Ratio | 34.72 |
| PEG Ratio | -3.967 |
| Price to Book Value | 11.60 |
| Price | 196.48 |
| Earnings Yield | -4.06% |
| PEGY Ratio | -3.967 |